Choosing an Estrogen Patch for HRT

Many menopause estrogen patches contain estradiol. An estrogen-only patch usually requires a separate progestogen plan with a uterus, because systemic estrogen can stimulate the lining. A combined patch supplies a progestogen as well as estrogen.

Levonorgestrel is different from micronized progesterone. A combined patch is not simply an estradiol patch with an oral progesterone dose built into it. Its specific formulation and evidence determine the prescribed regimen.

After hysterectomy, estrogen alone often meets routine HRT needs, although some histories require a different plan. The clinician should establish that before choosing a product.

A patch strength is commonly expressed in milligrams or micrograms delivered per day. The label separately states how many days the patch is worn. A 0.05 mg/day estradiol patch may use a weekly or twice-weekly design, depending on the product.

Patch area, total hormone content, adhesive, and application instructions can differ. The prescriber should choose the product and dose; the pharmacist should explain its schedule. Do not infer interchangeability from patch size or the amount of hormone printed on the packet.

A weekly patch reduces the number of change days. A twice-weekly product gives a different routine. Consider which schedule is easier to remember and whether a particular adhesive stays comfortable and attached. These practical differences can affect consistent use.

Transdermal estrogen enters through the skin and has a more favorable venous-clot risk profile than oral HRT in NICE guidance. NICE recommends considering it when clot risk is increased, including in people with a BMI over 30.

That comparison does not remove a patch's contraindications. US patch labels list histories such as venous clots, stroke or heart attack, breast cancer, and liver disease. A previous event may require specialist assessment or another treatment.

A route change also does not settle the breast-cancer or endometrial-risk discussion. The hormone combination, dose, duration, and personal history remain relevant. Discuss the complete prescription when comparing a tablet and patch.

• Confirm the full product name, both hormones if combined, and daily delivery strength.
• Write down changing days and any separate progestogen schedule.
• Check the permitted skin sites, site rotation, and detached-patch instructions.
• Ask what bleeding pattern to expect and how to report skin reactions or other effects.

Use clean, dry skin on a site approved for the exact product. Avoid irritated areas and anything that interferes with adhesion. A repeated skin reaction or detachment can prompt a review of technique, another patch, or another transdermal form.

If changing from a combined patch to estrogen alone, the new plan must state how uterine protection continues. A supply shortage or lower price should lead to a reviewed substitution, with written instructions for the whole regimen.